Description of a nationwide structure for monitoring nosocomial outbreaks of (highly resistant) microorganisms in the Netherlands: characteristics of outbreaks in 2012–2021

Sjoukje HS Woudt, Annelot F Schoffelen, Florine NJ Frakking, E Ascelijn Reuland, Juliëtte A Severin, Marije den Drijver, Anja Haenen, Marga MG Nonneman, Daan W Notermans, Desiree CM aan de Stegge, Sacha F de Stoppelaar, Christina MJE Vandenbroucke-Grauls, Sabine C de Greeff
{"title":"Description of a nationwide structure for monitoring nosocomial outbreaks of (highly resistant) microorganisms in the Netherlands: characteristics of outbreaks in 2012–2021","authors":"Sjoukje HS Woudt, Annelot F Schoffelen, Florine NJ Frakking, E Ascelijn Reuland, Juliëtte A Severin, Marije den Drijver, Anja Haenen, Marga MG Nonneman, Daan W Notermans, Desiree CM aan de Stegge, Sacha F de Stoppelaar, Christina MJE Vandenbroucke-Grauls, Sabine C de Greeff","doi":"10.1186/s13756-023-01350-9","DOIUrl":null,"url":null,"abstract":"Before 2012, established national surveillance systems in the Netherlands were not able to provide a timely, comprehensive epidemiological view on nosocomial outbreaks. The Healthcare-associated Infections and AntiMicrobial Resistance Monitoring Group (SO-ZI/AMR) was initiated in 2012 for timely national nosocomial outbreak monitoring and risk assessment. This paper aims to describe the achievements of the SO-ZI/AMR by presenting characteristics of outbreaks reported in 2012–2021. Hospitals and, since 2015, long-term care facilities (LTCF) were requested to report outbreaks when (1) continuity of care was threatened, or (2) transmission continued despite control measures. A multi-disciplinary expert panel (re-)assessed the public health risk of outbreaks during monthly meetings, using 5 severity phases and based on data collected via standardised questionnaires. We descriptively studied the panel’s consensus-based severity classification, distribution of (highly resistant) microorganisms, and duration and size of outbreaks between April 2012 and December 2021. In total, 353 hospital outbreaks and 110 LTCF outbreaks were reported. Most outbreaks (hospitals: n = 309 (88%), LTCF: n = 103 (94%)) did not progress beyond phase 1 (no public health implications, outbreak expected to be controlled within two months), one hospital outbreak reached phase 4 (insufficient/ineffective response: possible public health threat, support offered). Highly resistant microorganisms (HRMO) were involved in 269 (76%) hospital and 103 (94%) LTCF outbreaks. Most outbreaks were caused by methicillin-resistant Staphylococcus aureus (MRSA; n = 93 (26%) in hospitals, n = 80 (72%) in LTCF), vancomycin-resistant Enterococcus faecium (VRE; n = 116 (33%) in hospitals, n = 2 (2%) in LTCF) and highly resistant Enterobacterales (n = 41 (12%) in hospitals, n = 20 (18%) in LTCF). Carbapenemase-producing gram-negative bacteria were involved in 32 (9.1%) hospital and five (4.5%) LTCF outbreaks. In hospitals, VRE outbreaks had the longest duration (median 2.3; range 0.0-22.8 months) and widest range of affected patients (median 9; range 2-483). The SO-ZI/AMR provided national insight into the characteristics of nosocomial outbreaks over the past decade. HRMO outbreaks – mostly caused by MRSA, VRE (in hospitals) and highly resistant Enterobacterales – occurred regularly, but most of them were controlled quickly and did not develop into a public health threat. The SO-ZI/AMR has become a solid monitoring body, essential to assess risks and raise awareness of potential HRMO threats.","PeriodicalId":501612,"journal":{"name":"Antimicrobial Resistance & Infection Control","volume":"73 3 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Antimicrobial Resistance & Infection Control","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s13756-023-01350-9","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Before 2012, established national surveillance systems in the Netherlands were not able to provide a timely, comprehensive epidemiological view on nosocomial outbreaks. The Healthcare-associated Infections and AntiMicrobial Resistance Monitoring Group (SO-ZI/AMR) was initiated in 2012 for timely national nosocomial outbreak monitoring and risk assessment. This paper aims to describe the achievements of the SO-ZI/AMR by presenting characteristics of outbreaks reported in 2012–2021. Hospitals and, since 2015, long-term care facilities (LTCF) were requested to report outbreaks when (1) continuity of care was threatened, or (2) transmission continued despite control measures. A multi-disciplinary expert panel (re-)assessed the public health risk of outbreaks during monthly meetings, using 5 severity phases and based on data collected via standardised questionnaires. We descriptively studied the panel’s consensus-based severity classification, distribution of (highly resistant) microorganisms, and duration and size of outbreaks between April 2012 and December 2021. In total, 353 hospital outbreaks and 110 LTCF outbreaks were reported. Most outbreaks (hospitals: n = 309 (88%), LTCF: n = 103 (94%)) did not progress beyond phase 1 (no public health implications, outbreak expected to be controlled within two months), one hospital outbreak reached phase 4 (insufficient/ineffective response: possible public health threat, support offered). Highly resistant microorganisms (HRMO) were involved in 269 (76%) hospital and 103 (94%) LTCF outbreaks. Most outbreaks were caused by methicillin-resistant Staphylococcus aureus (MRSA; n = 93 (26%) in hospitals, n = 80 (72%) in LTCF), vancomycin-resistant Enterococcus faecium (VRE; n = 116 (33%) in hospitals, n = 2 (2%) in LTCF) and highly resistant Enterobacterales (n = 41 (12%) in hospitals, n = 20 (18%) in LTCF). Carbapenemase-producing gram-negative bacteria were involved in 32 (9.1%) hospital and five (4.5%) LTCF outbreaks. In hospitals, VRE outbreaks had the longest duration (median 2.3; range 0.0-22.8 months) and widest range of affected patients (median 9; range 2-483). The SO-ZI/AMR provided national insight into the characteristics of nosocomial outbreaks over the past decade. HRMO outbreaks – mostly caused by MRSA, VRE (in hospitals) and highly resistant Enterobacterales – occurred regularly, but most of them were controlled quickly and did not develop into a public health threat. The SO-ZI/AMR has become a solid monitoring body, essential to assess risks and raise awareness of potential HRMO threats.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
荷兰(高抗药性)微生物院内爆发监测全国性结构描述:2012-2021 年爆发的特点
2012 年之前,荷兰已建立的国家监测系统无法及时、全面地提供有关非医院感染爆发的流行病学信息。医疗相关感染和抗微生物耐药性监测小组(SO-ZI/AMR)于 2012 年成立,旨在及时监测全国性的非社会性疫情并进行风险评估。本文旨在通过介绍 2012-2021 年报告的疫情特点,描述 SO-ZI/AMR 所取得的成就。要求医院以及自 2015 年起要求长期护理机构(LTCF)在以下情况下报告疫情:(1) 护理的连续性受到威胁,或 (2) 尽管采取了控制措施但传播仍在继续。一个多学科专家小组在每月的会议上,根据标准化问卷收集的数据,按照 5 个严重程度阶段对疫情爆发的公共卫生风险进行(重新)评估。我们对专家小组基于共识的严重性分类、(高抗药性)微生物的分布以及 2012 年 4 月至 2021 年 12 月期间疫情暴发的持续时间和规模进行了描述性研究。共报告了 353 起医院疫情暴发和 110 起 LTCF 疫情暴发。大多数疫情(医院:n = 309 (88%),LTCF:n = 103 (94%))没有超过第 1 阶段(对公共卫生没有影响,预计疫情将在两个月内得到控制),有一起医院疫情达到了第 4 阶段(应对不足/无效:可能对公共卫生构成威胁,已提供支持)。269起(76%)医院疫情和103起(94%)LTCF疫情涉及高度耐药微生物(HRMO)。大多数疫情是由耐甲氧西林金黄色葡萄球菌(MRSA;医院为 93 例(26%),LTCF 为 80 例(72%))、耐万古霉素肠球菌(VRE;医院为 116 例(33%),LTCF 为 2 例(2%))和高度耐药肠杆菌(医院为 41 例(12%),LTCF 为 20 例(18%))引起的。在 32 例(9.1%)医院和 5 例(4.5%)长期护理设施爆发的疫情中,均涉及产碳青霉烯酶的革兰氏阴性菌。在医院中,疱疹病毒爆发的持续时间最长(中位数为 2.3 个月;范围为 0.0-22.8 个月),受影响的患者范围最广(中位数为 9 人;范围为 2-483 人)。SO-ZI/AMR提供了对过去十年中医院内爆发特点的全国性洞察。HRMO疫情--主要由 MRSA、VRE(医院)和高耐药性肠杆菌引起--经常发生,但大多数疫情很快得到控制,没有发展成为公共卫生威胁。SO-ZI/AMR 已成为一个可靠的监测机构,对于评估风险和提高对潜在 HRMO 威胁的认识至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Should my child be given antibiotics? A systematic review of parental decision making in rural and remote locations Pharmacies and use of antibiotics: a cross sectional study in 19 Arab countries Assessing infection prevention and control structures in German hospitals after the COVID-19 pandemic using the WHO infection prevention and control assessment framework (IPCAF): results from 660 hospitals and comparison with a pre-pandemic survey One decade of point-prevalence surveys for carriage of extended-spectrum beta-lactamase-producing enterobacterales: whole genome sequencing based prevalence and genetic characterization in a large Dutch teaching hospital from 2013 to 2022 Surveillance of antimicrobial utilization in Africa: a systematic review and meta-analysis of prescription rates, indications, and quality of use from point prevalence surveys
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1